ES2032861T3 - Procedimiento para preparar un medicamento a base de 5-hetero- o aril-substituido-imidazo (2,1-a)isoquinolina. - Google Patents

Procedimiento para preparar un medicamento a base de 5-hetero- o aril-substituido-imidazo (2,1-a)isoquinolina.

Info

Publication number
ES2032861T3
ES2032861T3 ES198787810387T ES87810387T ES2032861T3 ES 2032861 T3 ES2032861 T3 ES 2032861T3 ES 198787810387 T ES198787810387 T ES 198787810387T ES 87810387 T ES87810387 T ES 87810387T ES 2032861 T3 ES2032861 T3 ES 2032861T3
Authority
ES
Spain
Prior art keywords
hydrogen
imidazo
isoquinoline
hetero
medication
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787810387T
Other languages
English (en)
Inventor
William Joseph Houlihan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Pharma GmbH
Sandoz AG
Original Assignee
Sandoz Erfindungen Verwaltungs GmbH
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Erfindungen Verwaltungs GmbH, Sandoz AG filed Critical Sandoz Erfindungen Verwaltungs GmbH
Application granted granted Critical
Publication of ES2032861T3 publication Critical patent/ES2032861T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)

Abstract

COMPUESTOS DE FORMULA (I) EN DONDE CADA R ES INDEPENDIENTEMENTE HIDROGENO O METIL; R1 ESTA EN POSICION 8- O 9- Y REPRESENTA HIDROGENO, CLORO, FLUOR O ALQUILO C1-5 Y R2 REPRESENTA TIENIL, FURIL O (II) EN DONDE CADA R0 REPRESENTA INDEPENDIENTEMENTE HIDROGENO, FLUOR, CLORO, ALQUILO C1-10, ALCOXI C1-10 O ALQUILTIO C1-10 O UN R0 ES HIDROGENO Y EL OTRO REPRESENTA TRI-(ALQUILO C1-3 SILIL, TRIFLUOROMETIL, FENIL MONOCLOROFENIL, MONOFLUOROFENIL (III) EN DONDE X, Y, R3, R3'' O R4 SON COMO DEFINIDOS DEL MISMO O DOS R0 SOBRE EL METILENDIOXI QUE FORMA ATOMOS DE CARBONO ADYACENTES. LOS COMPUESTOS ESTAN INDICADOS PARA SU USO EN EL TRATAMIENTO DE LA BRONCOCONTRICCION MEDIATIZADA POR PAF Y DE LA EXTRAVASACION.
ES198787810387T 1986-07-14 1987-07-07 Procedimiento para preparar un medicamento a base de 5-hetero- o aril-substituido-imidazo (2,1-a)isoquinolina. Expired - Lifetime ES2032861T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88511586A 1986-07-14 1986-07-14
US1351587A 1987-02-11 1987-02-11

Publications (1)

Publication Number Publication Date
ES2032861T3 true ES2032861T3 (es) 1993-03-01

Family

ID=26684931

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787810387T Expired - Lifetime ES2032861T3 (es) 1986-07-14 1987-07-07 Procedimiento para preparar un medicamento a base de 5-hetero- o aril-substituido-imidazo (2,1-a)isoquinolina.

Country Status (22)

Country Link
EP (1) EP0258175B1 (es)
JP (1) JPH01500270A (es)
KR (1) KR960003609B1 (es)
AT (1) ATE74357T1 (es)
AU (1) AU604739B2 (es)
CA (1) CA1317942C (es)
CY (1) CY1828A (es)
DE (1) DE3777919D1 (es)
DK (1) DK170213B1 (es)
ES (1) ES2032861T3 (es)
FI (1) FI88159C (es)
GR (1) GR3004258T3 (es)
HK (1) HK71295A (es)
HU (1) HU206114B (es)
IE (1) IE60277B1 (es)
IL (1) IL83164A (es)
MY (1) MY101895A (es)
NZ (1) NZ221054A (es)
PH (1) PH24430A (es)
PL (1) PL154159B1 (es)
SG (1) SG8595G (es)
WO (1) WO1988000587A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4910206A (en) * 1986-07-14 1990-03-20 Sandoz Pharmaceuticals Corp. 5-hetero-or aryl-substituted-imidazo(2,1-a)isoquinolines and their use as PAF receptor antagonists
EP0338993A1 (en) * 1988-04-21 1989-10-25 Sandoz Ag 6-Aryl-substituted-4h-thieno[2,3-e][1,2,4]triazolo [3,4-c][1,4]diazepines
ATE118777T1 (de) * 1988-05-05 1995-03-15 Sandoz Ag 5-aryl-substituierte-2,3-dihydro-imidazo(1,2- a>furo(3,2-c>- oder thieno(2,3-c>pyridine.
US5939090A (en) 1996-12-03 1999-08-17 3M Innovative Properties Company Gel formulations for topical drug delivery
CN1076728C (zh) * 1999-02-05 2001-12-26 浙江大学 2-芳基咪唑并[2,1-a]异喹啉的衍生物及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1347493A (en) * 1971-02-11 1974-02-27 Aspro Nicholas Ltd Benzazine derivatives

Also Published As

Publication number Publication date
DE3777919D1 (de) 1992-05-07
PH24430A (en) 1990-06-25
CY1828A (en) 1995-12-01
FI88159C (fi) 1993-04-13
EP0258175A3 (en) 1988-05-04
PL266801A1 (en) 1988-09-29
AU604739B2 (en) 1991-01-03
FI881165A (fi) 1988-03-11
CA1317942C (en) 1993-05-18
IL83164A (en) 1991-05-12
ATE74357T1 (de) 1992-04-15
IE871876L (en) 1988-01-14
IE60277B1 (en) 1994-06-29
JPH01500270A (ja) 1989-02-02
HUT46005A (en) 1988-09-28
WO1988000587A3 (en) 1988-04-07
EP0258175A2 (en) 1988-03-02
FI881165A0 (fi) 1988-03-11
NZ221054A (en) 1990-10-26
EP0258175B1 (en) 1992-04-01
DK138388A (da) 1988-03-14
IL83164A0 (en) 1987-12-31
JPH0588713B2 (es) 1993-12-24
WO1988000587A2 (en) 1988-01-28
HK71295A (en) 1995-05-19
FI88159B (fi) 1992-12-31
SG8595G (en) 1995-06-16
AU7694187A (en) 1988-02-10
KR880701718A (ko) 1988-11-04
GR3004258T3 (es) 1993-03-31
KR960003609B1 (en) 1996-03-20
DK170213B1 (da) 1995-06-19
MY101895A (en) 1992-02-15
HU206114B (en) 1992-08-28
DK138388D0 (da) 1988-03-14
PL154159B1 (en) 1991-07-31

Similar Documents

Publication Publication Date Title
YU161786A (en) Process for obtaining substituted bridged diazabicycloalkyl hynoline carbonic acids
DE69201948D1 (de) Verwendung von 1,3-oxathiolanalogen von nukleosiden zur herstellung eines arzneimittels zur behandlung von hepatitis-b.
HUT59377A (en) Process for producing drugs containing new aromatic rings
ATE35137T1 (de) Thieno(2,3-d)pyrimidin-derivate und deren salze.
ES2032861T3 (es) Procedimiento para preparar un medicamento a base de 5-hetero- o aril-substituido-imidazo (2,1-a)isoquinolina.
LV10235A (lv) Jauni esteri to iegusanas panemiens farmaceitiska kompozicija arstesanas metode
DE3860300D1 (de) Tieftemperaturschmieroel.
MY102921A (en) Amino-alcohol derivatives and processes for their preparation.
TW336929B (en) Benzenesulphonamide derivatives, their preparation and their application in therapy
ES2008067T3 (es) Analogos de prostaciclina (pgi2).
ES2045282T3 (es) Un procedimiento para la preparacion de antraciclinona 4-sustituida.
FR2491470B1 (es)
SE8500307L (sv) Nya, antiviruella medel
GR3000969T3 (en) Alkyl carboxamides of pyridyl alkyl amines, their preparation and their use as medicaments
DE69111311D1 (de) 2-Tetrahydrofuran-Enantiomerderivate, Zwischenprodukte davon und ihre Herstellung.
ATE75747T1 (de) Verfahren zur herstellung von antibiotika.
EP0396078A3 (de) 1-Hydroxi-azolverbindungen und diese enthaltende Fungizide
TH11132EX (th) อนุพันธ์ออกเซเทน การเตรียมและการใช้อนุพันธ์เหล่านี้เป็นสารต่อต้านเชื้อราหรือเป็นสารฆ่าเชื้อรา

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 258175

Country of ref document: ES